Ann: 2022 Annual Report to Shareholders, page-9

They burnt that much trying to get ten patients, think how much trying to get 500. Big money needed but who will fund it ? What are the new funds buying as they need a safety plan to recoup funds , they can't sell on market as there is no liquidity , that leaves the MRX , intellectual property and patents. The main value is in the Nanoparticles which they have no Patent on. I would be worried that they are milking this with the large pay rises and renumeration packages until the taps turned off. Look at who Bob recently started working for , its the people who purchase the Nanoparticles it would be easy for them to start manufacturing thier own Nanoparticles with Bob now working for them and there being no Patent over them.

Something seems fishy.